Co-ordinated Cancer Immunotherapy

 

Zucero Therapeutics is an Australian-based biotechnology company committed to the discovery and development of modified sugar compounds for the treatment of cancer. PG545 (pixatimod, pINN) has emerged as Zuceroís first clinical candidate and is classified as an immunomodulatory agent that enhances the host immune systemís ability to suppress cancer.

 

 

 

 

Home† |† Technology† |† People† |† Publications† |† Contacts